US Patent D959015 COVID immunoassay test device
Patent D959015 was granted and assigned to Zhejiang Orient Gene Biotech on July, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent D959015 COVID immunoassay test device
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
